Novartis gets first pay-out from Swiss insurance policy
This article was originally published in Clinica
Executive Summary
Why is Novartis so doggedly pursuing full ownership of Alcon, an M&A transaction that rates among the most protracted the Swiss pharma group has ever undertaken?